Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aprea Therapeutics Inc
(NQ:
APRE
)
4.150
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aprea Therapeutics Inc
< Previous
1
2
3
4
5
Next >
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....
Via
Benzinga
FDA Lifts Clinical Hold On Aprea's Eprenetapopt Trial In Myeloid Malignancies
December 09, 2021
The FDA removed the full clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) trial evaluating the combination of eprenetapopt, with acalabrutinib or...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 09, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
You Ask, We Analyze: The Bull, Bear Case For Camber Energy And Aprea Stocks
October 07, 2021
On Wednesday evening, Benzinga asked its Benzinga Pro community which tickers they’d like analyzed. From the replies Benzinga selected these two tickers for technical...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 29, 2021
Gainers Regencell Bioscience (NASDAQ:RGC)...
Via
Benzinga
48 Biggest Movers From Yesterday
September 29, 2021
Gainers Gogo Inc. (NASDAQ: GOGO) shares climbed 37.6% to close at $16.82 on Tuesday after the company raised the long-term financial targets announced during Q4 2020 earnings....
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 21, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 30.95% to $8.08 during Tuesday's regular session. As of 12:30 EST, this security is trading at a...
Via
Benzinga
Aprea Therapeutics Stock Jumps After Eprenetapopt Combo Data Presentation At ESMO
September 21, 2021
Aprea Therapeutics Inc (NASDAQ: APRE) presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase 1/2 trial in advanced solid tumors....
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
18 Stocks Moving in Tuesday's Pre-Market Session
September 21, 2021
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 20, 2021
Gainers Verastem (NASDAQ:VSTM) shares moved upwards by 22.1% to $3.37 during Monday's pre-market session. The company's market cap stands at $609.1 million....
Via
Benzinga
24 Stocks Moving in Monday's Pre-Market Session
September 20, 2021
Gainers Verastem, Inc. (NASDAQ: VSTM) rose 30.8% to $3.61 in pre-market trading after the company announced a mini oral presentation highlighting updated data from the ongoing...
Via
Benzinga
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Biotech stocks declined for the week ending Sept. 17, extending the losses from the previous week. European Society for Medical Oncology presentations, vaccine news, clinical...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021
August 20, 2021
Upgrades For Investors Bancorp Inc (NASDAQ:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2021
August 16, 2021
Upgrades For Planet Fitness Inc (NYSE:PLNT), Roth...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 13, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 13, 2021
August 13, 2021
Upgrades For ACV Auctions Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 13, 2021
Gainers Biolase (NASDAQ:BIOL) stock moved upwards by 42.49% to $0.9 during Friday's pre-market session. The company's market cap stands at $135.3 million. As per...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 12, 2021
Gainers Xenetic Biosciences (NASDAQ:XBIO) shares rose 20.37% to $3.9 during Thursday's pre-market session. The company's market cap stands at $37.8 million....
Via
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...
Via
Benzinga
Exposures
Product Safety
Aprea Therapeutics Drops After FDA Clinical Hold On Another Blood Cancer Study
August 12, 2021
After instituting a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) myeloid malignancies program, the FDA has placed a clinical hold...
Via
Benzinga
Exposures
Product Safety
Aprea Therapeutics Stock Drops On FDA Clinical Hold On Eprenetapopt Myeloid Malignancy Trials
August 06, 2021
The FDA has instituted a partial clinical hold on Aprea Therapeutics Inc's (NASDAQ: APRE) clinical trials of eprenetapopt (APR-246) combined with...
Via
Benzinga
Exposures
Product Safety
Analyzing Aprea Therapeutics's Unusual Options Activity
July 21, 2021
On Wednesday, shares of Aprea Therapeutics (NASDAQ:APRE) saw unusual options activity. After the option alert, the stock price moved up to $5.2. Sentiment: NEUTRAL Option Type:...
Via
Benzinga
Aprea Stock Pops As Eprenetapopt Combo Regime Shows 58% Relapse-Free Survival, 79% Overall Survival At 1-Year Post-Transplant
July 21, 2021
Aprea Therapeutics Inc (NASDAQ: APRE) has announced results from its Phase 2 trial evaluating eprenetapopt with azacitidine for post-transplant maintenance therapy...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 01, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
June 17, 2021
Gainers Midatech Pharma (NASDAQ:MTP) stock rose 36.76% to $2.79 during Thursday's regular session. Midatech Pharma's stock is trading at a volume of 69.8 million...
Via
Benzinga
48 Biggest Movers From Yesterday
June 17, 2021
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highlighted the launch of its Amazon Storefront. Orphazyme A/S...
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles Over 300 Points; Federal Reserve Maintains Interest Rates
June 16, 2021
Toward the end of trading Wednesday, the Dow traded down 0.92% to 33,983.29 while the NASDAQ fell 0.68% to 13,977.59. The S&P also fell, dropping 0.74% to 4,215.21. The U.S....
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.